LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Variant classification summary
NM_000051.4:c.6975+13dupT
ATM
· NP_000042.3:p.?
· NM_000051.4
GRCh37: chr11:108196957 G>GT
·
GRCh38: chr11:108326230 G>GT
Gene:
ATM
Transcript:
NM_000051.4
Final call
Likely Benign
BP4 supporting
BP7 supporting
Variant details
Gene
ATM
Transcript
NM_000051.4
Protein
NP_000042.3:p.?
gnomAD AF
0.00010193895348475826 (v4.1)
ClinVar
Likely benign
OncoKB
Classification rationale
Interpretation summary
Generated evidence synthesis
1
BP4 (Supporting): SpliceAI max delta 0.007 is at or below the 0.1 benign threshold.
2
BP7 (Supporting): the +13 intronic position satisfies the deep-intronic (>+7) definition.
3
Combined, BP4 and BP7 Supporting satisfy Rule19, yielding Likely Benign.
Final determination:
ATM VCEP v1.5 criteria-combination Rule19 classifies a variant as Likely Benign when at least two benign supporting criteria are met.
Criteria assessment
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
| Criterion | Status | Rationale | Evidence used |
|---|---|---|---|
| PVS1 | Not met | Not met: SpliceAI predicts no splice impact (max delta 0.007), so loss-of-function and nonsense-mediated decay are not supported. |
cspec
vcep_atm_pvs1_1_5
spliceai
pvs1_gene_context
pvs1_variant_assessment
|
| PS1 | Not assessed | Not assessed: no known pathogenic reference variant at the same position or splice motif is available for comparison. |
cspec
vcep_atm_ps1_1_5
spliceai
|
| PS2 | N/A | Not applicable: the ATM expert panel specifies PS2 cannot be used for this gene's conditions. |
cspec
|
| PS3 | Not assessed | Not assessed: no variant-specific functional assay result for this exact duplication was available. |
cspec
vcep_clingen_hbop_atm_supplementary_tables_1_and_2_v1
vcep_suppl_tables1_pmid_40580951
|
| PS4 | Not assessed | Not assessed: no case-control study or effect estimate exists for this exact variant. |
cspec
PMID:17508274
PMID:18163131
PMID:24418350
|
| PM1 | N/A | Not applicable: the ATM expert panel excludes PM1, and the variant is intronic with no amino-acid residue. |
cspec
|
| PM2 | Not met | Not met: total allele frequency 0.01019% exceeds the 0.001% PM2 threshold. |
cspec
gnomad_v4
|
| PM3 | Not met | Not met: group maximum allele frequency 0.032389% exceeds the 0.01% eligibility limit. |
cspec
vcep_atm_pm3_bp2_1_5
gnomad_v4
|
| PM4 | Not met | Not met: intronic duplication is not a stop-loss variant, the only class PM4 covers. |
cspec
|
| PM5 | Not met | Not met: no observed RNA splicing impact, and SpliceAI max delta 0.007 is below the required evidence. |
cspec
vcep_atm_pvs1_1_5
spliceai
|
| PM6 | N/A | Not applicable: the ATM expert panel excludes PM6 for this gene's conditions. |
cspec
|
| PP1 | Not assessed | Not assessed: no affected relatives or segregation results were available. |
cspec
|
| PP2 | N/A | Not applicable: the ATM expert panel specifies PP2 is not used. |
cspec
|
| PP3 | Not met | Not met: SpliceAI max delta 0.007 is below the 0.2 supporting threshold. |
cspec
spliceai
|
| PP4 | N/A | Not applicable: the ATM expert panel prohibits use of PP4. |
cspec
|
| PP5 | N/A | Not applicable: no expert-panel submissions exist for this variant's ClinVar record. |
cspec
clinvar
|
| BA1 | Not met | Not met: group maximum allele frequency 0.032389% is below the 0.5% BA1 threshold. |
cspec
gnomad_v4
|
| BS1 | Not met | Not met: group maximum allele frequency 0.032389% is below the 0.05% BS1 threshold. |
cspec
gnomad_v4
|
| BS2 | N/A | Not applicable: the ATM expert panel specifies BS2 is not used. |
cspec
|
| BS3 | Not assessed | Not assessed: no functional result demonstrating normal ATM function for this exact duplication was available. |
cspec
vcep_clingen_hbop_atm_supplementary_tables_1_and_2_v1
vcep_suppl_tables1_pmid_40580951
|
| BS4 | N/A | Not applicable: the ATM expert panel excludes BS4 for this gene's conditions. |
cspec
|
| BP1 | N/A | Not applicable: the ATM expert panel specifies BP1 is not used. |
cspec
|
| BP2 | Not assessed | Not assessed: no unaffected-carrier observation, trans variant, or phase information was available. |
cspec
vcep_atm_pm3_bp2_1_5
|
| BP3 | N/A | Not applicable: the ATM expert panel designates BP3 as not used. |
cspec
|
| BP4 | Met | Met (Supporting): SpliceAI max delta 0.007 is at or below the 0.1 benign threshold. |
cspec
spliceai
|
| BP5 | N/A | Not applicable: the ATM expert panel prohibits use of BP5. |
cspec
|
| BP6 | N/A | Not applicable: no expert-panel submission exists on this variant's ClinVar record. |
cspec
clinvar
|
| BP7 | Met | Met (Supporting): the +13 intronic position satisfies the deep-intronic (>+7) definition. |
cspec
|
Disclaimer:
The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.